![](/img/cover-not-exists.png)
543PMIR-31-3P IS A PREDICTIVE BIOMARKER OF CETUXIMAB EFFECTS IN A POST-HOC ANALYSIS IN THE NEW EPOC STUDY
Laurent-Puig, P., Bridgewater, J.A., Primrose, J., Pugh, S., Thomas, G.J., Moutasim, K., Rousseau, F., Fontaine, K., Vazart, C., Decaulne, V., Leclair, A., Genin, B., Imbeaud, S., Liebaert, F., PiasecVolume:
25
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdu333.45
Date:
September, 2014
File:
PDF, 64 KB
2014